Skip to main content

Clinical Trials Using DNA Vaccine

Review the clinical trials studying dna vaccine on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 1-9 of 9

Degarelix with or without pTVG-AR and with or without Nivolumab for the Treatment of Prostate Cancer
Status: Active
Location: 2 locations
A Pair of Vaccinations (pNGVL4aCRTE6E7L2) and (TA-CIN) for the Treatment of Patients with HPV16 Positive Cervical Neoplasia
Status: Active
Location: 2 locations
A Vaccine (9pNGVL4aCRTE6E7L2 HPV DNA Vaccine) for the Treatment of HPV16 Positive High-Grade Cervical Intraepithelial Lesions
Status: Active
Location: 2 locations
A Vaccine (STEMVAC) with Standard Endocrine-Based Therapy or Chemotherapy for the Treatment of Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer
Status: Active
Location: Fred Hutch/University of Washington/Seattle Children's Cancer Consortium, Seattle, Washington
Concurrent WOKVAC Vaccination, Chemotherapy, and HER2-Targeted Monoclonal Antibody Therapy before Surgery for the Treatment of Patients with Breast Cancer
Status: Active
Location: Fred Hutch/University of Washington/Seattle Children's Cancer Consortium, Seattle, Washington
An Investigational Vaccine (pNGVL4a-Sig/E7[detox]/HSP70 and TA-HPV) Prior to Cell Collection in Healthy Haploidentical Stem Cell Transplant Donors
Status: Active
Location: Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland
pTVG-HP DNA Vaccine + Nivolumab + Targeted Radiation Therapy to Resistant Lesions for the Treatment of Biochemically Recurrent, Oligometastatic Prostate Cancer
Status: Active
Location: University of Wisconsin Carbone Cancer Center - University Hospital, Madison, Wisconsin
A Cancer Vaccine (STEMVAC) in Combination with Chemotherapy for the Treatment of PD-L1 Negative Metastatic Triple-Negative Breast Cancer
Status: Approved
Location: Fred Hutch/University of Washington/Seattle Children's Cancer Consortium, Seattle, Washington
Vaccine Therapy with or without Imiquimod in Treating Patients with High-Grade Cervical Intraepithelial Neoplasia
Status: Active
Location: Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland